Ryan Halsted
Stock Analyst at RBC Capital
(4.55)
# 1,008
Out of 5,090 analysts
126
Total ratings
69.2%
Success rate
18.6%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Rated: Buy | $185 → $226 | $211.36 | +6.93% | 8 | Oct 28, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $319 | $267.33 | +19.33% | 9 | Oct 27, 2026 | |
| MEDP Medpace Holdings | Reiterated: Buy | $692 | $652.01 | +6.13% | 8 | Oct 22, 2026 | |
| HCSG Healthcare Services Group | Reiterated: Hold | $24 | $24.52 | -2.12% | 7 | Oct 21, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $276 | $250.48 | +10.19% | 3 | Oct 12, 2026 | |
| COR Cencora | Reiterated: Hold | $330 | $330.84 | -0.25% | 3 | Oct 6, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $322 | $359.41 | -10.41% | 8 | Oct 6, 2026 | |
| DOCS Doximity | Reiterated: Buy | $28 | $32.76 | -14.53% | 11 | Oct 6, 2026 | |
| EVH Evolent Health | Reiterated: Hold | $3 | $4.30 | -30.23% | 7 | Oct 6, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $108 | $102.47 | +5.40% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $845 | $994.58 | -15.04% | 3 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $32.12 | +43.21% | 8 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $12.44 | +52.73% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $21.48 | +44.32% | 9 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $18.15 | +32.23% | 11 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $28.00 | +57.14% | 10 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $10.39 | n/a | 4 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $34.30 | n/a | 1 | Oct 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $76.37 | n/a | 1 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $181.52 | n/a | 3 | May 12, 2016 |
ICON Public Limited Company
Oct 28, 2026
Rated: Buy
Price Target: $185 → $226
Current: $211.36
Upside: +6.93%
IQVIA Holdings
Oct 27, 2026
Reiterated: Buy
Price Target: $319
Current: $267.33
Upside: +19.33%
Medpace Holdings
Oct 22, 2026
Reiterated: Buy
Price Target: $692
Current: $652.01
Upside: +6.13%
Healthcare Services Group
Oct 21, 2026
Reiterated: Hold
Price Target: $24
Current: $24.52
Upside: -2.12%
Cardinal Health
Oct 12, 2026
Reiterated: Buy
Price Target: $276
Current: $250.48
Upside: +10.19%
Cencora
Oct 6, 2026
Reiterated: Hold
Price Target: $330
Current: $330.84
Upside: -0.25%
Charles River Laboratories International
Oct 6, 2026
Reiterated: Buy
Price Target: $322
Current: $359.41
Upside: -10.41%
Doximity
Oct 6, 2026
Reiterated: Buy
Price Target: $28
Current: $32.76
Upside: -14.53%
Evolent Health
Oct 6, 2026
Reiterated: Hold
Price Target: $3
Current: $4.30
Upside: -30.23%
HealthEquity
Oct 6, 2026
Reiterated: Buy
Price Target: $108
Current: $102.47
Upside: +5.40%
Oct 6, 2026
Reiterated: Hold
Price Target: $845
Current: $994.58
Upside: -15.04%
Oct 6, 2026
Reiterated: Buy
Price Target: $46
Current: $32.12
Upside: +43.21%
Oct 6, 2026
Reiterated: Buy
Price Target: $19
Current: $12.44
Upside: +52.73%
Oct 6, 2026
Reiterated: Buy
Price Target: $31
Current: $21.48
Upside: +44.32%
Oct 6, 2026
Reiterated: Buy
Price Target: $24
Current: $18.15
Upside: +32.23%
Oct 6, 2026
Reiterated: Buy
Price Target: $44
Current: $28.00
Upside: +57.14%
Jan 12, 2017
Upgraded: Buy
Price Target: n/a
Current: $10.39
Upside: n/a
Oct 6, 2016
Reiterated: Hold
Price Target: n/a
Current: $34.30
Upside: n/a
Sep 9, 2016
Reiterated: Hold
Price Target: n/a
Current: $76.37
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $22
Current: $181.52
Upside: n/a